Bicycle Therapeutics (BCYC) Equity Ratio (2018 - 2025)
Historic Equity Ratio for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to 0.81.
- Bicycle Therapeutics' Equity Ratio fell 289.88% to 0.81 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.81, marking a year-over-year decrease of 289.88%. This contributed to the annual value of 0.83 for FY2024, which is 3302.33% up from last year.
- According to the latest figures from Q3 2025, Bicycle Therapeutics' Equity Ratio is 0.81, which was down 289.88% from 0.8 recorded in Q2 2025.
- In the past 5 years, Bicycle Therapeutics' Equity Ratio ranged from a high of 0.84 in Q1 2025 and a low of 0.48 during Q2 2023
- Moreover, its 5-year median value for Equity Ratio was 0.69 (2022), whereas its average is 0.7.
- As far as peak fluctuations go, Bicycle Therapeutics' Equity Ratio crashed by 3067.04% in 2023, and later soared by 7053.05% in 2024.
- Bicycle Therapeutics' Equity Ratio (Quarter) stood at 0.72 in 2021, then decreased by 8.62% to 0.66 in 2022, then decreased by 5.52% to 0.62 in 2023, then soared by 33.02% to 0.83 in 2024, then dropped by 2.32% to 0.81 in 2025.
- Its Equity Ratio was 0.81 in Q3 2025, compared to 0.8 in Q2 2025 and 0.84 in Q1 2025.